XRCC1 shows potential as a prognostic and immunological pan-cancer biomarker

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 1, entitled, “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.”

European Commission spells out new proposals for health technology assessments

The European Commission is encouraging member countries to work together more effectively on assessing and paying for new therapies and health technologies with a proposal

March 6, 2024

Stroke survivors more likely to experience abnormal sleep patterns

People who have had a stroke may be more likely to sleep too much or too little compared to those without prior stroke, according to

September 12, 2024

Prime Medicine lays off workers as it trims pipeline

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning to everyone except

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.